CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 14, 2022 · earnings

NRXP earnings: a negative outcome, -10.0%

On November 14, 2022, NRX Pharmaceuticals, Inc. reached its earnings. The result was a negative outcome, and the stock moved -10.0% in the window around the event. It had already run +32.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$10.00
1d before
$9.00
Event day
$9.31
1d after
$11.40
5d after

Pre-catalyst setup

+32.9%
30-day run-up
8395%
30-day volatility
3.0×
volume spike